Review
Does chemotherapy benefit the patient with a central nervous system glioma?
Affiliations
- PMID: 3079493
Item in Clipboard
Review
Does chemotherapy benefit the patient with a central nervous system glioma?
Oncology (Williston Park).
1987 Nov.
Abstract
The authors discuss the results of clinical trials assessing the value of chemotherapy for brain tumors in the adjuvant setting as well as at recurrence. Adjuvant chemotherapy does benefit some patients with malignant brain gliomas. Improved survival rates seem to be related to an increased number of long-term survivors. The most effective chemotherapy is BCNU or a combination of CCNU, procarbazine, and vincristine (PCV). Drugs that potentiate radiation therapy, such as hydroxyurea and BUdR, are also useful in some patients.
Comment in
-
Does chemotherapy really help patients with CNS gliomas?Oncology (Williston Park). 1988 Sep;2(9):14, 16-7. Oncology (Williston Park). 1988. PMID: 3275062 No abstract available.
Similar articles
-
Radiochemotherapy of malignant glioma in adults. Clinical experiences.Strahlenther Onkol. 2003 Apr;179(4):219-32. doi: 10.1007/s00066-003-1027-y. Strahlenther Onkol. 2003. PMID: 12707711 Review.
-
[Chemo-radiotherapy for malignant brain tumors].Gan To Kagaku Ryoho. 2002 May;29(5):669-76. Gan To Kagaku Ryoho. 2002. PMID: 12040669 Review. Japanese.
-
[Chemotherapy of malignant glioma. Results of studies of the EORTC group of brain tumors].Rev Neurol (Paris). 1992;148(6-7):435-40. Rev Neurol (Paris). 1992. PMID: 1448663 Clinical Trial. French.
-
Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1147-52. doi: 10.1016/j.ijrobp.2003.08.024. Int J Radiat Oncol Biol Phys. 2004. PMID: 15001257 Clinical Trial.
-
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.Clin Cancer Res. 2000 Oct;6(10):3878-84. Clin Cancer Res. 2000. PMID: 11051233 Clinical Trial.
Cited by
-
Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results.J Neurooncol. 2003 Feb;61(3):267-73. doi: 10.1023/a:1022580610598. J Neurooncol. 2003. PMID: 12675321
-
Cost of temozolomide therapy and global care for recurrent malignant gliomas followed until death.Neuro Oncol. 2005 Apr;7(2):189-95. doi: 10.1215/S1152851704000687. Neuro Oncol. 2005. PMID: 15831237 Free PMC article. Clinical Trial.
-
A therapeutic trial of radiation therapy with Vincristine, etoposide, and Procarbazine (VVP) in high grade intracranial gliomas--an Eastern Cooperative Oncology Group Study (E2392).J Neurooncol. 1998 Mar;37(1):55-62. doi: 10.1023/a:1005867520788. J Neurooncol. 1998. PMID: 9525838 Clinical Trial.
-
VP-16, vincristine and procarbazine with radiation therapy for treatment of malignant brain tumors.J Neurooncol. 1990 Apr;8(2):163-6. doi: 10.1007/BF00177840. J Neurooncol. 1990. PMID: 2162915
-
Phase I study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomas.Br J Cancer. 2003 Jul 21;89(2):248-51. doi: 10.1038/sj.bjc.6601043. Br J Cancer. 2003. PMID: 12865911 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical